Rayner Cataract Set 1
Payments companies reported to CMS as associated with Rayner Cataract Set 1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rayner Cataract Set 1, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rayner Cataract Set 1
These are the largest totals companies reported as associated with Rayner Cataract Set 1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ronald Lo Pinto | Plainview, NY | Ophthalmology | $423.24 |
| Geoffrey Collett | Bellaire, TX | Ophthalmology | $400.06 |
| Mehrdad Aghai | Gardena, CA | Ophthalmology | $335.89 |
| Jack Chapman | Gainesville, GA | Ophthalmology | $328.32 |
| Brett Bielory | Rutherford, NJ | Ophthalmology | $328.19 |
| Jeffrey Crowder | Gainesville, GA | Ophthalmology | $317.09 |
| Michael Raizman | Boston, MA | Ophthalmology | $296.06 |
| Michael Sable | Hicksville, NY | Ophthalmology | $286.19 |
| Kevin Kovach | Elmhurst, IL | Ophthalmology | $277.71 |
| Marius Gradianu | Elmhurst, IL | Ophthalmology | $252.17 |
Prescribed Rayner Cataract Set 1?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.